Abstract

Simple SummaryDespite breakthroughs in medicine, cancer remains one of the most feared diseases. Traditionally, chemotherapies have been the treatment of choice. However, concerns about stability and poor solubility prevent them from being widely used. Destruction of healthy cells, hair loss, and drug resistance are all common side effects. In this aspect, nanotechnology opens up new avenues for cancer treatment. ZnO NPs are one of the most valuable metal oxide nanoparticles in cancer treatment owing to their high biocompatibility and low toxicity. The ability of ZnO NPs to selectively trigger the formation of reactive oxygen species and induce apoptosis has been critically appraised in this review. They are also the best contenders for diagnosis and tailored drug delivery in cancer therapeutics. Here, we extensively summarize the role of ZnO NPs in cancer diagnosis, target drug delivery, and treatment, which will help in future research advancements in the field of cancer theranostic.Cancer is regarded as one of the most deadly and mirthless diseases and it develops due to the uncontrolled proliferation of cells. To date, varieties of traditional medications and chemotherapies have been utilized to fight tumors. However, their immense drawbacks, such as reduced bioavailability, insufficient supply, and significant adverse effects, make their use limited. Nanotechnology has evolved rapidly in recent years and offers a wide spectrum of applications in the healthcare sectors. Nanoscale materials offer strong potential for curing cancer as they pose low risk and fewer complications. Several metal oxide NPs are being developed to diagnose or treat malignancies, but zinc oxide nanoparticles (ZnO NPs) have remarkably demonstrated their potential in the diagnosis and treatment of various types of cancers due to their biocompatibility, biodegradability, and unique physico-chemical attributes. ZnO NPs showed cancer cell specific toxicity via generation of reactive oxygen species and destruction of mitochondrial membrane potential, which leads to the activation of caspase cascades followed by apoptosis of cancerous cells. ZnO NPs have also been used as an effective carrier for targeted and sustained delivery of various plant bioactive and chemotherapeutic anticancerous drugs into tumor cells. In this review, at first we have discussed the role of ZnO NPs in diagnosis and bio-imaging of cancer cells. Secondly, we have extensively reviewed the capability of ZnO NPs as carriers of anticancerous drugs for targeted drug delivery into tumor cells, with a special focus on surface functionalization, drug-loading mechanism, and stimuli-responsive controlled release of drugs. Finally, we have critically discussed the anticancerous activity of ZnO NPs on different types of cancers along with their mode of actions. Furthermore, this review also highlights the limitations and future prospects of ZnO NPs in cancer theranostic.

Highlights

  • zinc oxide nanoparticles (ZnO NPs) can be manufactured via physical processes such as vapor deposition, plasma, and ultrasonic irradiation, which are less common than chemical methods [34,37,38]

  • Cytotoxic as well as anti-angiogenic effects of ZnO NPs synthesized from an algae, Sargassum muticum, were evaluated on HepG2 cells and results affirmed that concentrations of 2800 μg/mL at 72 h of exposure left only 4.5% of cells alive, thereby affecting a survival rate of 95%

  • At doses of 4 and 8 μg/mL, overexpression of caspase 3 was detected, whereas significant overexpression of caspase 8 was only observed at the dose of 8 μg/mL. These findings showed that ZnO NPs have the ability to induce apoptosis in both cancer cell types [160]

Read more

Summary

Hallmarks of Cancer

IMscoouvnetriendg, mevaikdienngcethseurgagpeysdtsiftfhicaut lZt,niOf nNotPismapreoscsaipbaleb.lTeoofddiaegsntroosyeincagnccaenrcaetracnelelsarblyy sthtaegper,oitdiuscvtiiotanl toof rdeeavcetliovpe onxeywgedniasgpneocisetisc(RpOroSc)e,dimurpeslyoinrgtothiemirpproovteenttihael aesxiasntinagntoicnaensc.eTroagseonlvte[4t0h,e6s2e] 4. Role of ZnO NPs in Diagnosis of Cancer Despite advances in the development of novel therapy methods, cancer continues to be one of the main causes of death in humans. Role of ZnO NPs in Diagnosis of Cancer Despite advances in the development of novel therapy methods, cancer continues to be one of the main causes of death in humans This is primarily due to the failure to detect malignancies at an early stage. As these polymers are safe and cheap, they can be used in cell imaging as fluorescent probes in in vitro as well, implying potential uses in biological sectors [76]

ZnO NPs in Sustained and Targeted Delivery of Anticancerous Drugs
ZnO NPs
ZnO Nanocomposite
In Vitro and In Vivo Anticancerous Activity of ZnO NPs
Liver Cancer
Lung Cancer
Breast Cancer
Osteosarcoma
Colon Carcinoma
Cervical Cancer
Other Cancers
Method of Synthesis of Chemical method
Findings
Mechanism Involved in Anticancerous Activity of ZnO NPs via Apoptosis Pathway

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.